S06-058 Engineered EGF polypeptides for improved epidermal and epithelial wound healing Jennifer Cochran Karl Wittrup
S11-262 Epidermal growth factor (EGF) mutants for wound healing and tissue engineering A team of Stanford engineers has identified first-in-class epidermal growth factor (EGF) mutants with enhanced activity. These mutants can stimulate increased EGF receptor activation at 10-fold lower concentrations than wild-type EGF. Jennifer Cochran James Swartz Bertrand Lui Jennifer Andersen Cheuk Lun Leung Bob Chen